Contrast sensitivity and quality of life following intravitreal ranibizumab injection for central retinal vein occlusion
- 27 August 2021
- journal article
- research article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 107 (2), 254-260
- https://doi.org/10.1136/bjophthalmol-2021-319863
Abstract
Synopsis/precis We investigated the relationship between contrast sensitivity (CS) and vision-related quality of life (VR-QOL) in patients with central retinal vein occlusion following ranibizumab intravitreal injection; CS showed a stronger association with VR-QOL than visual acuity. Background/aims To investigate the relationship between CS, VR-QOL and optical coherence tomography (OCT) findings in patients with cystoid macular oedema secondary to central retinal vein occlusion (CRVO-CMO) following intravitreal injection of ranibizumab. Methods This was a multicentre, open-label, single-arm, prospective study. The study included 23 patients with CRVO-CMO who were followed up for 12 months after treatment. The best-corrected visual acuity (BCVA), letter contrast sensitivity (LCS) and OCT images were obtained every month. For VR-QOL assessment, the 25-item National Eye Institute Visual Function Questionnaire (VFQ-25) was administered to the patients before treatment and at 3, 6 and 12 months following treatment. Results The LCS and VFQ-25 composite score improved significantly from baseline to 12 months following treatment. The multiple regression analysis revealed that the LCS of the affected eye and BCVA of the fellow eye were related to the VFQ-25 composite score following treatment. The LCS improvement showed a significant correlation with the improvement in the VFQ-25 composite score, whereas the BCVA improvement was not correlated with the improvement in the VFQ-25 composite score. Stepwise multiple regression analyses revealed that, at the time of macular oedema resolution, the distance between the external limiting membrane and retinal pigment epithelium (ELM-RPE) and average ganglion cell-inner plexiform layer (GCIPL) thickness were associated with LCS. Conclusion CS had a stronger association with VR-QOL than with BCVA in patients with CRVO-CMO. With the resolution of macular oedema, CS was associated with ELM-RPE thickness and average GCIPL thickness.Keywords
Funding Information
- Novartis Pharma (no grant / award number)
This publication has 37 references indexed in Scilit:
- Contrast Sensitivity and Color Vision in Eyes With Retinitis Pigmentosa and Good Visual Acuity: Correlations With SD-OCT FindingsOphthalmic Surgery, Lasers and Imaging Retina, 2012
- Contrast visual acuity in patients with retinitis pigmentosa assessed by a contrast sensitivity testerIndian Journal of Ophthalmology, 2012
- Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III StudyOphthalmology, 2011
- Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in Age-Related Macular DegenerationInvestigative Ophthalmology & Visual Science, 2011
- Efficacy and safety of anti-vascular endothelial growth factor (VEGF) therapy with intravitreal ranibizumab (Lucentis) for naive retinal vein occlusion: 1-year follow-upBritish Journal of Ophthalmology, 2010
- Vision-Related Quality of Life and Visual Function after Vitrectomy for Various Vitreoretinal DisordersInvestigative Ophthalmology & Visual Science, 2010
- Vision-related quality of life and visual function in patients undergoing vitrectomy, gas tamponade and cataract surgery for macular holeBritish Journal of Ophthalmology, 2009
- Three-dimensional Imaging of the Foveal Photoreceptor Layer in Central Serous Chorioretinopathy Using High-speed Optical Coherence TomographyOphthalmology, 2007
- Contrast sensitivity as an outcome measure in patients with subfoveal choroidal neovascularisation due to age-related macular degenerationEye, 2004
- The reliability of the Pelli-Robson contrast sensitivity chartOphthalmic and Physiological Optics, 1990